BGI Genomics stated during an institutional research on October 24 that as of the end of the third quarter of this year, the overall sample size of its colorectal cancer public health project exceeded 400,000 cases, with revenue approaching 100 million yuan. In the future, the company will accelerate its transformation from a "testing service" model to a comprehensive model of "products + services + data," forming a dual-drive pattern of C-end + B-end